|
Assay Explorer
Find Ready-To-Go Assays to Run Your Samples Now
Assay Explorer is currently populated with assays from several panels including:
- OncoCarta v1.0 – Sequenom's first cancer panel with 238 mutations and 19 oncogenes
- OncoCarta v2.0 – An extended cancer panel with 166 mutations and 18 oncogenes and tumor suppressors
- MelaCarta v1.0 – A melanoma-specific cancer panel
- Learn more...
Featured Publications
DNA methylation is normally repressive but can activate genes when the methylated sites lie outside promoter regions.
- With the assistance of the MassARRAY system and EpiTYPER Methylation Analysis tools it was found that Dnmt3a methylates intergenic regions
- Learn more...
The grape microvine – a model system for rapid forward and reverse genetics of grapevines
- Homozygosity was analyzed by genotyping 263 SNPs using iPLEX Gold
- Learn more...
Diverse somatic mutation patterns and pathway alterations in human cancers
- Over >2,500 somatic mutations were identified in 441 tumors.
- Successful design and implementation of >2,500 assays using Sequenom's iPLEX® Gold chemistry.
- Learn more...
|
Upcoming Webinar:
Date: Sep. 29th, 2010 7:00 am PST
Presenter: Dr. Richard Buggs
Topic: Detecting presence/absence and relative expression levels of homeo-alleles using Sequenom technology.

User Group Meetings
Date: Oct. 6-8, 2010
Location: Newton, Massachusetts

Date: Oct. 13-14, 2010
Location: San Mateo, California

|
Note: The MassARRAY platform, OncoCarta, iPLEX, iSEQ, EpiTYPER and MelaCarta are for Research Use Only. Not for use in diagnostic procedures. |